Clinical trial
Fixed Dose Heparin Study
NCT00182403 · McMaster University, Other · Completed
Key facts
| NCT number | NCT00182403 |
|---|---|
| Title | Fixed Dose Heparin Study |
| Official title | Fixed Dose Unfractionated Heparin for Initial Treatment of Venous Thromboembolism |
| Lead sponsor | McMaster University, Other |
| Collaborators | Heart and Stroke Foundation of Ontario |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | UFH 250 U/kg or LMWH 100 U/kg sc twice daily |
| Enrollment | 866 |
| Start date | Sep 1, 1998 |
| Completion | May 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 7, 2017 |
| Countries | Canada, New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: